Insider Transactions in Q2 2021 at Biodesix Inc (BDSX)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 05
2021
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,219
+48.68%
|
$0
$0.77 P/Share
|
Apr 01
2021
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,713
+36.0%
|
$38,713
$1.08 P/Share
|